The Longevity Registry

§ — Researched for · Aging pathways & mitochondrial function

Peptides researched for aging pathways & mitochondrial function

The peptides marketed for 'aging itself' — epitalon, MOTS-c, and mitochondrial-derived peptides — have no controlled human outcome data. In July 2026 an FDA advisory committee recommended listing both for compounding, against the advice of FDA's scientists; FDA has not decided.

A
Approved drug with randomized controlled trials for the approved indication
B
Human clinical data exists, but no approval for the researched use
C
Animal or in-vitro data only, no controlled human trials
D
No published clinical data; use rests on anecdote

Reviewed October 2026 · Sources: FDA, EMA

02 — What is being studied

The research field, in plain terms.

This is the most mechanistic corner of peptide research. Mitochondrial-derived peptides encoded in mitochondrial DNA, such as MOTS-c, are studied for AMPK signalling, insulin sensitivity and exercise capacity in rodents and cell models. Epitalon is studied for pineal and telomerase-related mechanisms, largely in Russian-language work from the 1990s and 2000s.

The endpoints that would matter for an aging claim — survival, incidence of age-related disease, validated aging biomarkers measured against placebo in people — have not been studied for either compound. What exists is pathway data in animals and open-label human observation. Both were reviewed by FDA's compounding advisory committee in July 2026, which recommended both for the 503A Bulks List against the advice of FDA's own scientists; FDA has not decided. That is the clearest available summary of the evidence base as of October 2026.

03 — The table

Every peptide in this group, with its status.

PeptideResearched forEvidenceRegulatory statusAs of
MOTS-cInsulin sensitivity, exercise capacity, metabolic regulation, aging biology.CNot FDA-approved. Removed from 503A Category 2 on April 15, 2026. On July 23, 2026, the advisory committee voted 7–5 (two abstentions) to recommend it for the 503A Bulks List, against the advice of FDA's scientists. FDA has not decided; it cannot yet be compounded under section 503A.2026-10-22
EpitalonTelomerase activation, melatonin regulation, lifespan extension.DNot FDA-approved. Removed from 503A Category 2 on April 15, 2026. On July 24, 2026, the advisory committee voted 7–4 (one abstention) to recommend it for the 503A Bulks List, against the advice of FDA's scientists. FDA has not decided; it cannot yet be compounded under section 503A.2026-10-22

04 — Per peptide

Status first, then research.

C

MOTS-c

Regulatory status · United States · as of October 2026

Not FDA-approved. Removed from 503A Category 2 on April 15, 2026. On July 23, 2026, the advisory committee voted 7–5 (two abstentions) to recommend it for the 503A Bulks List, against the advice of FDA's scientists. FDA has not decided; it cannot yet be compounded under section 503A.

Source: FDA 503A Bulks List · PCAC meeting records · verified October 2026

Researched forInsulin sensitivity, exercise capacity, metabolic regulation, aging biology.

Full profile: MOTS-c →
D

Epitalon

Regulatory status · United States · as of October 2026

Not FDA-approved. Removed from 503A Category 2 on April 15, 2026. On July 24, 2026, the advisory committee voted 7–4 (one abstention) to recommend it for the 503A Bulks List, against the advice of FDA's scientists. FDA has not decided; it cannot yet be compounded under section 503A.

Source: FDA 503A Bulks List · PCAC meeting records · verified October 2026

Researched forTelomerase activation, melatonin regulation, lifespan extension.

Full profile: Epitalon →

05 — What the data does not show

The limits of this group.

Life extension, telomere lengthening or reversal of aging markers in humans have not been shown for any peptide.

06 — Questions for your physician

Six questions worth printing.

  1. 01What is your primary board certification, and in what year did you obtain it?
  2. 02Is this peptide approved for what you are prescribing it for — and if not, what is the legal basis on which you are supplying it?
  3. 03Which human trials support this use, and what were their size and duration?
  4. 04Where does the product come from, and can you show me a certificate of analysis for this batch?
  5. 05What outcome will we measure, when, and what happens if it does not improve?
  6. 06What is the total cost for the first three months, in writing?

Practices near you that offer peptide therapy

Every practice in the registry that lists peptide therapy, sorted by distance and nothing else. You contact the practice directly.

AgeReversalMD

La Jolla, CA

Focus matches this goal: Biological Age & Epigenetics, Cognition & Brain Health, Functional Medicine

No physician listed on the practice website

Ana Casas M.D. Anti-Aging and Regenerative Medicine

Alpharetta, GA

Focus matches this goal: Advanced Blood Biomarkers, Cancer Screening & Early Detection, Cognition & Brain Health

Physician credentials on file

Anatara Medicine

San Francisco, CA

Focus matches this goal: Advanced Blood Biomarkers, Biological Age & Epigenetics, Cognition & Brain Health

Ahvie Herskowitz, MD · Ann Lee, MD

Angel Longevity Medical Center

Studio City, CA

Focus matches this goal: Biological Age & Epigenetics, Cryotherapy / Sauna / Red Light, Functional Medicine

No physician listed on the practice website

Austin Regenerative Therapy

Austin, TX

Focus matches this goal: Advanced Blood Biomarkers, Cancer Screening & Early Detection, Cognition & Brain Health

Physician credentials on file

Authentic Health

Asheville, NC

Focus matches this goal: Advanced Blood Biomarkers, Concierge / Membership Model, DEXA / Body Composition

Physician credentials on file

Listed for transparency, not as an endorsement of any practice, substance or protocol. Most peptides are not FDA-approved for the uses they are offered for.

Reviewed October 2026 · Sources: FDA, EMA

This page reports on the state of research and regulation for orientation. It is not medical advice, not a recommendation for or against any substance, and not an offer. Regulatory status changes; the date shown is the date of our last verification. Discuss any treatment with a licensed physician.

Most peptides used in longevity practice are not FDA-approved for these uses. Check the status of each substance first.

Practices that offer peptide therapy